After skyrocketing beginning last autumn, shares of quantum computing company IonQ (NYSE: IONQ) came back to earth this year. The stock is still up more than 120% over the past year as of this ...

Nasdaq futures rose 0.4%. However, the high growth, tech heavy Nasdaq tumbled 4% into correction territory this week. The S&P shed. 3.6% over the last four days and closed at its lowest point since ...

Robin has worked as a credit cards, editor and spokesperson for over a decade. Prior to Forbes Advisor, she also covered credit cards and related content for other national web publications ...

Please view our advertising policy and product review methodology for more information. Chase Sapphire cardholders, get ready to unwind. Sapphire Reserve cardholders can receive one free year of Calm ...

After soaring following the election, Tesla (NASDAQ: TSLA) stock ran into a wall in February as a number of news items, macro challenges, and CEO Elon Musk's involvement in the Department of ...

$95 N/A 20.49% - 27.49% Variable Earn 60,000 bonus points Good to Excellent If you're new to travel rewards credit cards or just don't want to pay hundreds in annual fees, the Chase Sapphire ...

Shares of online learning platform company Nerdy (NYSE: NRDY) fell hard today after the company reported its fourth-quarter results yesterday. While sales and earnings beat Wall Street's consensus ...

And he is creating an iteration of his 18-karat pink gold cuff, set with aquamarines, peridots, tourmalines and sapphires, adding yellow enamel fish scales in large and small sizes, connected to ...

Hims and Hers' stock fell over 19% in after-hours trading on Monday after its CEO said the company would no longer sell compounded versions of mega-hit weight loss drugs. "We will have to start ...

Bitcoin has fallen below $90,000 for the first time this year, triggering a widespread sell-off in the crypto market while the U.S. remains asleep. At 4 a.m. ET, Bitcoin’s decline dragged the ...

Hims and Hers plans to stop selling compounded weight loss drugs after an FDA update. Hims and Hers' stock fell over 19% in after-hours trading on Monday. The FDA removed semaglutide injections ...

Palantir Technologies shares plunged Monday, extending losses following a report last week that the Trump administration directed the Pentagon to trim the U.S. defense budget. The report raised ...